Analyst Ratings for Bristol-Myers Squibb Co. (BMY)Updated: 2017-07-28
Bristol-Myers Squibb Co. (NYSE:BMY) was awarded an average rating of Overweight from investment analysts following the stock. Last month, BMY received an average rating of Overweight.
24 analysts issued ratings on the stock, where 10 gave BMY a buy rating, 1 gave an overweight rating, 10 issued a hold rating, 1 issued an underweight rating, and 2 gave a sell rating. Compared to three months ago, there has been an decrease of 1 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 1.
Investment analysts gave a few price targets for BMY. The highest price target was 68, which equates to a potential upside of 25.37 percent. The minimum price target given was 40, which equates to a potential downside of -26.25 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.
In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0.68 percent. That number becomes 4.27 percent if we expand the time horizon to include the past 3 months instead of just one. Over the past 30 days, FY earnings estimates have also changed upwards by 0.34 percent. If we look at the last 90 days instead, we find a net average change of 3.53 percent in FY estimates.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 3 analysts have revised their quarterly estimates upwards in the past 30 days, while 4 analysts made negative revisions. Over the same time period, 4 analysts revised their FY earnings estimates upwards, while 3 analysts decreased their estimates.
Analysts estimate earnings of BMY to grow at a rate of 3.52 percent. The PEG ratio of a stock is another value frequently studied by investors. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. PEG ratios below 1 are often considered desirable, although it is frequently more appropriate to compare PEG ratios to the company's peers. BMY has a PEG ratio of 5.6.
BMY has traded between a high of 76.48 and a low of 46.01 over the past year. Currently the stock is 17.89 percent higher than its low, and below the high by 29.08 percent. BMY has a P/E ratio of 19.72. Investors typically compare the P/E ratio to a company's peers in the industry. The BMY value stock report compares BMY to some of its peers using value stock charts. The market cap of BMY is $92.22 billion. BMY's next earnings release will be on 0000-00-00, which is days away.